Join Dr. Mitchel Berger, the Kathleen M. Plant Distinguished Professor and Chairman of the Department of Neurological Surgery at the University of California San Francisco and host Dr. Bill Rutenberg for a discussion of novel targeted therapies for the treatment of malignant brain tumors. Can immunoliposomes hone in like smart bombs attacking tumors not previously reachable?
Beyond Radiation and Chemotherapy
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Join Dr. Mitchel Berger, the Kathleen M. Plant Distinguished Professor and Chairman of the Department of Neurological Surgery at the University of California San Francisco and host Dr. Bill Rutenberg for a discussion of novel targeted therapies for the treatment of malignant brain tumors. Can immunoliposomes hone in like smart bombs attacking tumors not previously reachable?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
Evaluating Sleep Deprivation as a Risk Factor for Postpartum Depression
Reducing the Risk of Postpartum Depression Through Sleep Interventions
Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?